Guillermo E. Umpierrez

49.5k citations
559 papers · 36.6k · 33 hit papers · h-index 94

Impact in

    • Diabetes Management and Research
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients
    • Diabetes Treatment and Management
    • Diabetes Management and Education
    • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Nephrology top 0.5%
    • Chronic Kidney Disease and Diabetes

Papers in

    • Diabetes Management and Research 209
    • Diabetes Treatment and Management 158
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 153
    • Diabetes, Cardiovascular Risks, and Lipoproteins 32
    • Diabetes Management and Education 15
    • Chronic Kidney Disease and Diabetes 16

Guillermo E. Umpierrez

524 papers receiving 34.3k citations

Guillermo E. Umpierrez's Hit Papers

GLP-1RA Use and Thyroid Cancer Risk 2025 · 33 citations
330+2+4Years since publication100200300400500

Peers

Guillermo E. Umpierrez
Comparison fields: 5 of 172
  • Endocrinology, Diabetes and Metabolism 25.7k
  • Nephrology 1.4k
  • Cardiology and Cardiovascular Medicine 1.9k
  • Epidemiology 1.7k
  • Emergency Medical Services 336
Replace Irl B. Hirsch with:
Irl B. Hirsch United States
Richard M. Bergenstal United States
Vivian Andrew Fonseca United States
Simon R. Heller United Kingdom
Ildiko Lingvay United States
Lawrence S. Phillips United States
Robert A. Gabbay United States
Anne L. Peters United States
Janet B. McGill United States
Απόστολος Τσάπας Greece
Guillermo E. Umpierrez relative to Irl B. Hirsch United States Irl B. Hirsch's profile →
Citations per field
00.5×1.5×2.2×
Irl B. Hirsch · 1×
Citations per year

Countries citing papers authored by Guillermo E. Umpierrez

Since Specialization
Citations

This map shows the geographic impact of Guillermo E. Umpierrez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo E. Umpierrez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo E. Umpierrez more than expected).

Fields of papers citing papers by Guillermo E. Umpierrez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo E. Umpierrez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo E. Umpierrez. The network helps show where Guillermo E. Umpierrez may publish in the future.

Co-authors

The 25 scholars most cited alongside Guillermo E. Umpierrez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Guillermo E. Umpierrez Line = papers co-authored together Guillermo E. Umpierrez links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 559 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Hyperglycemia: An Independent Marker of In-Hospital Mortality in Patients with Undiagnosed Diabetes
Hit paper breakdown →
20021690
2
Hyperglycemic Crises in Adult Patients With Diabetes
Hit paper breakdown →
20091485
3
American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Hit paper breakdown →
20091072
4
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Hit paper breakdown →
2016916
5
Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline
Hit paper breakdown →
2012836
6
Consensus Statement By The American Association Of Clinical Endocrinologists And American College Of Endocrinology On The Comprehensive Type 2 Diabetes Management Algorithm – 2016 EXECUTIVE SUMMARY
Hit paper breakdown →
2016724
7
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Hit paper breakdown →
2011553
8
Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery
Hit paper breakdown →
2010546
9
American Association of Clinical Endocrinologists and American College of Endocrinology – Clinical Practice Guidelines for Developing A Diabetes Mellitus Comprehensive Care Plan – 2015 — Executive Summary
Hit paper breakdown →
2015545
10
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Hit paper breakdown →
2022539
11
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)
Hit paper breakdown →
2007526
12 2001505
13
American Association Of Clinical Endocrinologists And American College Of Endocrinology -Clinical Practice Guidelines For Developing A Diabetes Mellitus Comprehensive Care Plan – 2015
Hit paper breakdown →
2015475
14
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
Hit paper breakdown →
2021464
15
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary
Hit paper breakdown →
2020462
16
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
Hit paper breakdown →
2012440
17 2009422
18
Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary
Hit paper breakdown →
2018405
19 2004396
20 2006386

About Guillermo E. Umpierrez

Guillermo E. Umpierrez is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Physiology and Public Health, Environmental and Occupational Health, having authored 559 papers that have together received 36.6k indexed citations. Recurring topics across this work include Diabetes Management and Research (209 papers), Diabetes Treatment and Management (158 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (153 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (32 papers), Chronic Kidney Disease and Diabetes (16 papers), Diabetes Management and Education (15 papers), Pancreatic function and diabetes (10 papers) and Heart Failure Treatment and Management (10 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (25.7k citations), Nephrology (1.4k citations), Cardiology and Cardiovascular Medicine (1.9k citations), Epidemiology (1.7k citations) and Emergency Medical Services (336 citations). Guillermo E. Umpierrez has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Abbas E. Kitabchi, Dawn D. Smiley, Francisco J. Pasquel, Mary T. Korytkowski, Joseph N. Fisher, Limin Peng, Irl B. Hirsch, Scott D. Isaacs, DANIEL F. EINHORN and Leonard M. Thaler. Their work appears in journals such as Diabetes Care, Endocrine Practice, Diabetes, Journal of Diabetes Science and Technology and The Journal of Clinical Endocrinology & Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact